Table 6 Median OS among patients with intrahepatic cholangiocarcinoma by presence of cirrhosis and tumor stage
From: Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival
Cirrhosis/Surgical Intervention Status | N | Median Overall Survival Time in Months (95% CI) |
|---|---|---|
Cirrhosis Cohort | ||
Stage I | 63 | 132.0 (42.1, NE) |
Stage II | 46 | 22.2 (13.6, 67.7) |
Stage III | 15 | 23.9 (1.9, 53.2) |
Stage IV | 83 | 5.6 (3.5, 10.4) |
Non-Cirrhosis Cohort | ||
Stage 0a | – | 25.9 (9.1, NE) |
Stage I | 260 | 73.7 (55.7, 106.1) |
Stage II | 173 | 38.6 (31.5, 46.4) |
Stage III | 129 | 26.4 (19.6, 31.5) |
Stage IV | 295 | 12.2 (9.7, 15.7) |
Totala | – | 30.2 (27.1, 32.7) |